Drug Companies

When: Monday, 12/10/07 @ 7 PM
Who: Dr. Gilbert Chu MD PhD, Professor of Medicine & Biochemistry, Stanford University
The Deets:
Over the past 20 years, the use of prescribed medication has skyrocketed with many marketed directly to the public. In this new age, can we trust that drug companies have our best interests at heart?

Stanford’s Dr. Gilbert Chu will discuss the drug development/marketing process, specifically the case study of Merck & Vioxx. The FDA estimates 40,000 deaths associated to Vioxx. We will discuss the enormous potential for helping humanity with good drugs, the biology of Vioxx and heart attacks, and the analysis of clinical trials for Vioxx. Understanding what went wrong can lead to policy changes by industry, academia, and government that protect the welfare of patients.

The Presentation
To move to the next slide, click on the right side of the current slide. Click on the left side to go back.

Download the presentation here.
Video - Flash is required to view the online videos.
Part 1


Download Part 1 here. (50 mb Quicktime Movie)

Part 2


Download Part 2 here. (50 mb Quicktime Movie)

Pictures

Get macromedia Flash Player